DYNE THERAPEUTICS INC. - COMMON STOCK
15.68
05-2月-25 16:45:00
15 分の遅延
株式
+0.89
+6.02%
本日の幅
14.80 - 16.01
ISIN
N/A
ソース
NASDAQ
-
Dyne Therapeutics Reports Second Quarter 2021 Financial Results and Business Highlights
05 8 2021 07:30:01 提供 Nasdaq GlobeNewswire
-
25 6 2021 07:30:00 提供 Nasdaq GlobeNewswire
-
Dyne Therapeutics Announces Chief Scientific Officer Transition
02 6 2021 16:05:00 提供 Nasdaq GlobeNewswire
-
Dyne Therapeutics to Present at Jefferies Virtual Healthcare Conference
26 5 2021 07:30:00 提供 Nasdaq GlobeNewswire
-
Dyne Therapeutics Reports First Quarter 2021 Financial Results and Business Highlights
06 5 2021 07:29:00 提供 Nasdaq GlobeNewswire
-
Dyne Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Highlights
04 3 2021 07:35:00 提供 Nasdaq GlobeNewswire
-
Dyne Therapeutics Appoints Wildon Farwell, M.D., MPH, as Chief Medical Officer
04 3 2021 07:25:00 提供 Nasdaq GlobeNewswire
-
08 2 2021 07:30:00 提供 Nasdaq GlobeNewswire
-
Dyne Therapeutics Announces Pricing of $168 Million Public Offering
20 1 2021 20:05:29 提供 Nasdaq GlobeNewswire
-
10 1 2021 15:00:00 提供 Nasdaq GlobeNewswire
-
Dyne Therapeutics to Present at 39th Annual J.P. Morgan Healthcare Conference
05 1 2021 07:30:00 提供 Nasdaq GlobeNewswire